Transfection of endothelial cells with mutant BRAF has been reported to increase VEGF secretion, while in melanoma cells pharmacological BRAF inhibition promoted vascular stabilisation via a presumed decrease in aberrant angiogenesis [34]. The gene discussed is VEGFA; the disease is melanoma.